Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Pharm-country    crawled date : 2021 - 12 - 13    save search

Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
Published: 2021-12-13 (Crawled : 23:00) - biospace.com/
TRVN | $0.3653 -9.13% -10.05% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 6.24% H: 0.0% C: 0.0%

trv045 diabetic diabetes
Teleflex Receives Reimbursement Approval for the UroLift® System in JapanWill expand patient access to breakthrough BPH treatment
Published: 2021-12-13 (Crawled : 23:00) - biospace.com/
TFX | News | $207.38 -0.44% 0.0% 150K twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 0.0% C: 0.0%

urolift treatment approval
Harmony Biosciences Publishes Pitolisant Efficacy Data In CNS Drugs
Published: 2021-12-13 (Crawled : 16:00) - biospace.com/
HRMY | $29.05 -0.48% -0.48% 410K twitter stocktwits trandingview |
Health Technology
| | O: -3.85% H: 0.0% C: 0.0%

drug bioscience
Largest Study to Date Demonstrates Most Blood Cancer Patients Benefit From a Third Primary Dose of mRNA COVID-19 Vaccine
Published: 2021-12-13 (Crawled : 15:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.41% H: 0.0% C: 0.0%

covid-19 blood covid cancer vaccine
BIOHAVEN ANNOUNCES NURTEC® ODT RECEIVES FIRST GLOBAL APPROVAL OUTSIDE THE U.S. FOR PREVENTION OF MIGRAINE
Published: 2021-12-13 (Crawled : 13:00) - biospace.com/
BHVN | News 0 d | $42.16 -4.25% 0.85% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -2.49% H: 0.0% C: 0.0%

nurtec approval migraine
BrainStorm Cell Therapeutics Announces peer reviewed publication of NurOwn's® Phase 3 Study for ALS in Muscle and Nerve
Published: 2021-12-13 (Crawled : 13:00) - biospace.com/
BCLI | $0.503 -6.99% -7.51% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -3.36% H: 0.0% C: 0.0%

nurown therapeutics phase 3 als
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.